CDMRP Ovarian Cancer Proteogenomics Research Award

Archived

Defense Health Agency Contracting Activity - DHACA

Description

The OCRP Proteogenomics Research Award supports the use of proteomics and/or genomics to explore new concepts or theories in ovarian cancer. The award is intended to support the genomic and/or transcriptomic and/or proteomic analysis of currently available clinical specimens with a focus on answering biologic and pathophysiologic questions of clinical relevance in ovarian cancer. The proposed research question should be innovative and have the potential to make an impact on ovarian cancer.Clinical trials are not allowed under the Proteogenomics Research Award mechanism. The analysis of clinical trial-derived specimens and/or large patient specimen cohorts is encouraged. Preliminary data are not required but are allowed.

Who can apply

  • Unrestricted

Contact

CDMRP Help Desk <br/>Phone: 301-682-5507 <br/>Email: help@eBRAP.org
help@eBRAP.org

Key dates & funding
  • PostedFeb 8, 2021
  • ClosesJul 8, 2021
  • Program funding$800,000
  • Expected awards2
  • CFDA12.420

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro